Sentry BioPharma Services, Inc. Announces Headquarters Expansion and Additional US Facility Construction
November 8, 2023
Indianapolis-based company, Sentry Biopharma Services, Inc. (Sentry US) is celebrating the construction of a 55,000 square foot addition to its existing 83,000 square foot headquarters facility. Driven by client needs, this expansion will provide additional cGMP temperature-controlled storage, labeling/packaging and end-to-end logistics capabilities required to support the development and manufacturing of pharmaceuticals and medical devices. According to Tim J. Mitchell, President and CEO, “Sentry’s primary business is providing customized services to meet the needs of our 165+ global pharma clients and their unique needs. Protecting product integrity is our focus as we deliver life-saving drug products into and out of forty-five countries across the five continents.”
Pictured left to right – Clayton Force, John Warner, Alex Mitchell, Tim Mitchell, Harold Force and Pat Early
Sentry US is also constructing a second 50,000 square foot facility in Columbus, IN which will include cGMP temperature-controlled storage as well as stability, aliquoting and laboratory services. As a result of the two expansions, Sentry US’s workforce will grow to approximately 80 employees in 2024. Force Construction is expected to complete construction of the Columbus facility in January 2024 and the Indianapolis expansion by the end of 2024.
“These capital projects mark milestone expansions for Sentry, in keeping with our global growth strategy. The addition of a second US facility and associated service expansions as well as our European operation in Copenhagen, Denmark will continue to position us as a leader in temperature sensitive pharmaceutical product management.” – Alex Mitchell, VP, Operations
Groundbreaking ceremony on August 9, 2023
About Sentry BioPharma Services, Inc.
Sentry BioPharma Services, Inc. (Sentry US) is a Contract Service Organization (CSO) which supports the life science industry by offering cGMP temperature-controlled storage, distribution, labeling and packaging, Foreign Trade Zone (FTZ) storage, and end-to-end logistics services. The company’s mission is to deliver compliant, secure, and scalable services to entities that embrace an outsourcing strategy. Sentry US navigates public and private entities through evolving business, licensing, and regulatory landscapes while prioritizing product integrity in all steps of the temperature sensitive pharmaceutical life cycle. To learn more, visit https://sentrybps.com.
A wholly owned subsidiary of Sentry, Sentry BioPharma Services ApS, provides additional services and is located in Copenhagen, Denmark (https://sentrybioaps.com).